Author Correction: Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK

類似資料

• Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK
  著者:: Danielpour, David, 等
  出版事項: (2019)
• Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1
  著者:: Wagner, Verena, 等
  出版事項: (2014)
• Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155)
  著者:: Wani, Tasaduq Hussain, 等
  出版事項: (2021)
• Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells
  著者:: Gholizadeh, Shima, 等
  出版事項: (2018)
• Emerging Effects of Sepantronium Bromide (YM155) on MOLT-4 Cell Line Apoptosis Induction and Expression of Critical Genes Involved in Apoptotic Pathways
  著者:: Shojaei Moghadam, Kobra, 等
  出版事項: (2020)